samedan logo
home > pmps > autumn 2008 > keeping cool under increasing pressure
Pharmaceutical Manufacturing and Packing Sourcer

Keeping Cool under Increasing Pressure

In this time of global economic slowdown, with operating margins being squeezed, pharmaceutical companies are under pressure to cut costs, while at the same time ensuring that they comply with ever tougher legislation. This is especially true in the area of temperature-controlled shipping, where rising freight costs are set against a background of complex standards that vary from country to country and region to region.

While stringent laws and guidelines relating to the transportation of pharmaceuticals are necessary to protect the health of patients, complying with the regulations requires sophisticated and dependable transportation solutions. The extended distances and durations now being travelled by pharmaceutical products have led to the development of temperature-controlled packaging technology that is capable of protecting its contents in a wide range of ambient temperatures. This means that temperature critical drugs can be shipped safely and cost effectively, wherever their destination.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:

There are no comments in regards to this article.

Geraint Thomas graduated from Brunel University in 1996 with a Bachelor of Science in Industrial Product Design. After working as a Board Game Engineer for Hasbro toys, he joined Laminar Medica in 1998 as a Packaging Development Technologist with responsibility for packaging solutions and qualification packages for insulated shipper design. Now employed as Technical Director, Geraint has been instrumental in realising Laminar Medica’s development programme, including the expansion of the company’s qualification laboratory and R&D facility.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Maetrics appoints Dr Amie Smirthwaite to lead Clinical Practice discipline globally

Maetrics, an international leader in life sciences quality and regulatory consulting, has appointed Dr Amie Smirthwaite as Senior Director of the Global Clinical Practice.
More info >>

White Papers

Clinical Trials in Emerging Markets: Goldmines or Landmines?

Pharm-Olam, LLC

Over the past decade, biopharmaceutical companies have increasingly turned to emerging markets as a way to reduce clinical trial costs and timelines. Areas such as Eastern Europe, India, and Latin America—with their ready population of treatment naïve patients—can be an answer to the intense competition for patients seen in developed markets. Many of the countries within these regions may now be considered as “emerged” countries but yet, conducting trials in these regions does require some special attention and expertise. Before deciding to conduct studies in these areas, companies should have a full appreciation for the ethical, medical, regulatory, legal, and operational hurdles that must be surmounted for success. Here we highlight a number of those issues and offer our recommendations for how sponsor companies can deal with them effectively.
More info >>

Industry Events

World Vaccine Congress Europe

18-21 October 2020, Barcelona, Spain

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>



©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement